Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating BX-001N for preventing cardiac surgery-associated acute kidney injury and major adverse kidney events is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery-associated Acute Kidney Injury
• Ischemia-reperfusion Injury

Drugs mentioned

• BX-001N

Snippet

Sponsor: Bilix Co.,Ltd. | Conditions: Ischemia Reperfusion Injury, Cardiac Surgery Associated - Acute Kidney Injury | Phase 2 | Status: RECRUITING